Roundup Lawsuit Settlement Amounts: How Much Is a Case Worth in 2026?

Bayer's Historic $10.9 Billion Settlement

In June 2020, Bayer AG announced a landmark settlement of approximately $10.9 billion to resolve most of its pending Roundup litigation in the United States. The agreement covered roughly 125,000 claims filed by people who alleged that Roundup exposure caused them to develop Non-Hodgkin Lymphoma. The settlement did not include an admission of liability by Bayer.

The $10.9 billion was allocated across several categories: approximately $8.8 billion to resolve existing claims, $1.25 billion to address claims from individuals who had not yet filed but may do so in the future, and additional funds for class action settlements involving home gardeners and future science commitments.

The settlement was administered by a claims process that evaluated each plaintiff's case based on specific criteria, including the severity of their NHL diagnosis, the extent of their Roundup exposure, their age at diagnosis, and other case-specific factors. Claimants who accepted settlement offers received compensation and released their claims against Bayer.

Factors That Determine Your Roundup Settlement Amount

No two Roundup cases are alike, and compensation amounts vary significantly based on several key factors that attorneys use to assess the value of an individual claim:

• Severity and stage of NHL: More aggressive or advanced cancers that required extensive treatment — including chemotherapy, radiation, stem cell transplants, or bone marrow transplants — typically result in higher compensation
• Duration and intensity of Roundup exposure: Longer and more frequent use of Roundup generally supports a stronger causation argument and may increase claim value
• Occupational vs. residential exposure: Farmworkers, landscapers, and groundskeepers who used Roundup professionally often have the most documentable exposure histories
• Age at diagnosis: Younger plaintiffs who faced a lifetime of consequences from their diagnosis may receive higher compensation
• Medical expenses: Documented costs of cancer treatment, including hospitalizations, chemotherapy, radiation, and ongoing monitoring
• Lost income and earning capacity: Inability to work during or after treatment, or long-term career impact due to cancer
• Pain and suffering: Non-economic damages for physical pain, emotional distress, and diminished quality of life
• Punitive damages: In cases that go to trial and where juries find egregious corporate misconduct, punitive damages can dramatically increase total awards

An experienced mass tort attorney will evaluate all of these factors to provide an estimate of your claim's potential value before you decide whether to accept a settlement offer.

Notable Trial Verdicts That Set the Standard

While many Roundup cases settled out of court, a series of high-profile trial verdicts have shaped the landscape of the litigation and influenced settlement values across the board:

In 2018, Dewayne Johnson was awarded $289 million by a California jury (later reduced to $78 million on appeal). In the same year, plaintiff Edwin Hardeman was awarded $80 million in federal court. In 2019, a married couple — Alva and Alberta Pilliod — received a combined verdict of $2 billion (later reduced to $87 million). These early verdicts sent a powerful signal to Bayer about jury sentiment nationwide.

More recently, a Philadelphia jury in 2023 awarded $175 million to a plaintiff who had used Roundup on his Pennsylvania property for years before developing NHL. These ongoing verdicts continue to drive settlement negotiations and keep pressure on Bayer to compensate remaining claimants.

Current Status of Roundup Claims in 2026

Despite the massive 2020 settlement, Roundup litigation remains very much active in 2026. Bayer has faced thousands of new claims filed after the settlement and continues to defend itself in state and federal courts. The company has faced significant challenges in attempting to establish a global settlement that would bar future claims.

In late 2022 and 2023, Bayer announced it was setting aside additional funds to address remaining and future claims, with some estimates suggesting the total liability could ultimately exceed $16 billion. Analysts continue to watch for further developments, including potential additional global settlement attempts and the outcomes of ongoing appellate proceedings.

If you have been diagnosed with Non-Hodgkin Lymphoma and used Roundup, it is important to act promptly. Statutes of limitations vary by state and could bar your claim if you wait too long. Even if you believe the main settlement window has closed, there may still be options available to you.

How Legal Fees Work in Roundup Cases

The vast majority of Roundup attorneys work on a contingency fee basis, which means:

• You pay nothing upfront to hire an attorney
• The attorney advances all costs of litigation, including expert witnesses, court filing fees, and investigation costs
• If you win or settle, the attorney receives a percentage of the recovery, typically 33-40%
• If you do not recover anything, you owe nothing

This arrangement means that access to justice in Roundup cases is not dependent on your financial resources. The attorney has a direct financial incentive to maximize your recovery.

Frequently Asked Questions